SleepCited

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.

Colin Tuft, Elie Matar, Zoe Menczel Schrire, Ronald R Grunstein, Brendon J Yee et al.
Review Clinical interventions in aging 2023 41 citations

Plan d'étude

Type d'étude
Review
Population
Older adults (age >65 years) with insomnia and circadian rhythm sleep-wake disorders
Intervention
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. None
Comparateur
other hypnotic medications
Critère de jugement principal
Safety and adverse effects of melatonin in older adults with sleep disorders
Direction de l'effet
Positive
Risque de biais
Unclear

Résumé

Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population.

En bref

Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use, and there are several factors which increase the risk of adverse effects of melatonin in older adults.

Utilisé dans les revues de preuves